Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?

Peritoneal metastasis is common in gastric cancer. It is difficult to treat and carries a poor prognosis. Intraperitoneal (IP) delivery of chemotherapy can attain a higher drug exposure in the peritoneal cavity but with reduced systemic toxicity. Therefore, we hypothesized that IP paclitaxel with sy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastrointestinal surgery 2017-03, Vol.21 (3), p.425-433
Hauptverfasser:	Chan, Dexter Yak Seng, Syn, Nicholas Li-Xun, Yap, Rachel, Phua, Janelle Niam Sin, Soh, Thomas I. Peng, Chee, Cheng Ean, Nga, Min En, Shabbir, Asim, So, Jimmy Bok Yan, Yong, Wei Peng
Format:	Artikel
Sprache:	eng
Schlagworte:	2016 SSAT Plenary Presentation Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adenocarcinoma - surgery Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Capecitabine Carcinoma - surgery Cellular biology Chemotherapy Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Drug dosages Female Fluorouracil - administration & dosage Fluorouracil - analogs & derivatives Gastrectomy Gastric cancer Gastroenterology Gastrointestinal surgery Humans Infusions, Parenteral Male Medical prognosis Medicine Medicine & Public Health Metastasis Middle Aged Oxaloacetates Paclitaxel - administration & dosage Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - secondary Peritoneum - pathology Stomach Neoplasms - pathology Stomach Neoplasms - surgery Surgery Survival Rate Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!